SCHEMBL2223316

SCHEMBL2223316

Cc1ccc(Oc2ncc3nc(-c4cc(C)c(OCC(=O)O)c(C)c4)oc3n2)cc1

nearest known ligand 0.75

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
S1PR1 P21453 1/20 0.75
CSNK2A2 P19784 1/20 0.40
CSNK2B P67870 1/20 0.40
CSNK2A1 P68400 1/20 0.40
CETP P11597 1/20 0.39
SMN1; SMN2 Q16637 3/20 0.38
MAPT P10636 2/20 0.38
POLB P06746 1/20 0.38
KDM4E B2RXH2 2/20 0.38
ALDH1A1 P00352 1/20 0.38
PPARA Q07869 4/20 0.37
PPARG P37231 4/20 0.37
PTPN1 P18031 2/20 0.36
PPARD Q03181 6/20 0.36
FFAR1 O14842 1/20 0.35
GAA P10253 1/20 0.34
KMT2A Q03164 1/20 0.34
THRB P10828 1/20 0.34
RXFP1 Q9HBX9 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2223368 0.93 S1PR1 (0.83) S1PR1CETPMAPTKDM4EALDH1A1
SCHEMBL2222826 0.92 S1PR1 (0.73) S1PR1CETPSMN1; SMN2MAPTALDH1A1
SCHEMBL2222062 0.92 S1PR1 (0.82) S1PR1CETPMAPTALDH1A1PPARA
SCHEMBL14797017 0.90 S1PR1 (0.73) S1PR1CSNK2A2CSNK2BCSNK2A1MAPT
SCHEMBL14797067 0.90 S1PR1 (0.70) S1PR1PPARAPPARGPTPN1PPARD
SCHEMBL14797145 0.90 S1PR1 (0.77) S1PR1KDM4EALDH1A1PPARAPPARG
SCHEMBL2221025 0.90 S1PR1 (0.83) S1PR1CSNK2A2CSNK2BCSNK2A1CETP
SCHEMBL14797116 0.89 S1PR1 (0.76) S1PR1CETPPPARAPPARGPTPN1
SCHEMBL14797164 0.89 S1PR1 (0.73) S1PR1CETPPPARAPPARGPTPN1
SCHEMBL14797053 0.89 S1PR1 (0.76) S1PR1CETPPPARAPPARGPTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8846692-B2 Carboxylic acid derivatives having a 2,5-substituted oxazolopyrimidine ring SANOFI (FR) 2014-09-30 US disclosed
EP-2523962-B1 CARBOXYLIC ACID DERIVATIVES HAVING A 2,5-SUBSTITUTED OXAZOLOPYRIMIDINE RING SANOFI SA (FR) 2013-11-27 EP disclosed
US-20130079358-A1 CARBOXYLIC ACID DERIVATIVES HAVING A 2,5-SUBSTITUTED OXAZOLOPYRIMIDINE RING SANOFI (FR) 2013-03-28 US disclosed
EP-2523962-A1 CARBOXYLIC ACID DERIVATIVES HAVING A 2,5-SUBSTITUTED OXAZOLOPYRIMIDINE RING SANOFI (FR) 2012-11-21 EP disclosed
WO-2011086079-A1 CARBOXYLIC ACID DERIVATIVES HAVING A 2,5-SUBSTITUTED OXAZOLOPYRIMIDINE RING SANOFI-AVENTIS (FR) 2011-07-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130079358-A1 CARBOXYLIC ACID DERIVATIVES HAVING A 2,5-SUBSTITUTED OXAZOLOPYRIMIDINE RING OXGR1, EDNRA, EDF1 S1PR1 129/4885CSNK2A2 3722/4885CSNK2B 3728/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.